Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency

Mucopolysaccharidosis type II (MPS II), or Hunter syndrome, is the hereditary lysosomal storage disease caused by pathological variants in IDS gene. Such variants lead to iduronate-2-sulfatase enzyme deficiency and glycosaminoglycan catabolism disorder. Major clinical signs are central nervous syste...

Full description

Saved in:
Bibliographic Details
Main Authors: Nato D. Vashakmadze (Author), Leyla S. Namazova-Baranova (Author), Natalia V. Zhurkova (Author), Ekaterina Yu. Zakharova (Author), Grigory V. Revunenkov (Author), Tina V. Lobjanidze (Author), Marina A. Babaikina (Author)
Format: Book
Published: "Paediatrician" Publishers LLC, 2020-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items